0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Myopia and Presbyopia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-17H8203
Home | Market Reports | Health| Vision Care
Global and Japan Myopia and Presbyopia Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Myopia and Presbyopia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17H8203
Report
October 2024
Pages:154
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Myopia and Presbyopia Treatment - Market Size

The global market for Myopia and Presbyopia Treatment was estimated to be worth US$ 16350 million in 2023 and is forecast to a readjusted size of US$ 28630 million by 2030 with a CAGR of 8.3% during the forecast period 2024-2030

Myopia and Presbyopia Treatment - Market

Myopia and Presbyopia Treatment - Market

Myopia and presbyopia are conditions of the eye which result in a difficulty in viewing objects clearly. Myopia is the condition in which people have a trouble seeing objects at a distance while presbyopia is the condition where people are unable to clearly see the objects kept close to their eyes. Both these conditions are caused when the light entering the eye does not properly focus on the retina, leading to near sightedness in case of myopia. Presbyopia generally occurs among old people and is caused as a result of weakened muscles in the eye.
The Myopia and Presbyopia Treatment market is driven by the increasing prevalence of these vision disorders, especially due to lifestyle changes and prolonged use of digital devices. With myopia affecting a significant portion of the global population, there's a growing demand for effective treatment options to manage and correct this condition. Additionally, the aging population contributes to the demand for presbyopia treatment solutions. Technological advancements in ophthalmic devices and surgical procedures have introduced innovative treatments, such as LASIK, orthokeratology, and intraocular lenses, which offer improved visual outcomes. However, challenges include ensuring the safety and efficacy of these treatments, addressing potential side effects, and making these options accessible and affordable to a wider range of patients. Meeting these challenges and providing reliable, patient-friendly solutions will be essential for driving growth in the myopia and presbyopia treatment market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Myopia and Presbyopia Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Myopia and Presbyopia Treatment by region & country, by Type, and by Application.
The Myopia and Presbyopia Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myopia and Presbyopia Treatment.
Market Segmentation

Scope of Myopia and Presbyopia Treatment - Market Report

Report Metric Details
Report Name Myopia and Presbyopia Treatment - Market
Forecasted market size in 2030 US$ 28630 million
CAGR 8.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Myopia
  • Presbyopia
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis AG, Bausch & Lomb, Nidek Co., Ltd, Johnson & Johnson Vision, Biotech Healthcare, HumanOptics, Wuxi Vision Pro Ltd, HOYA Corporation, ZEISS, EssilorLuxottica, CooperVision, Ovctek, Alpha Corporation, EUCLID, Brighten Optix, Lucid Korea, WeiXing Optical, Contex, Jiangsu Green Stone Optical (SETO), Conant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Myopia and Presbyopia Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Myopia and Presbyopia Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Myopia and Presbyopia Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Myopia and Presbyopia Treatment - Market size in 2030?

Ans: The Myopia and Presbyopia Treatment - Market size in 2030 will be US$ 28630 million.

Who are the main players in the Myopia and Presbyopia Treatment - Market report?

Ans: The main players in the Myopia and Presbyopia Treatment - Market are Novartis AG, Bausch & Lomb, Nidek Co., Ltd, Johnson & Johnson Vision, Biotech Healthcare, HumanOptics, Wuxi Vision Pro Ltd, HOYA Corporation, ZEISS, EssilorLuxottica, CooperVision, Ovctek, Alpha Corporation, EUCLID, Brighten Optix, Lucid Korea, WeiXing Optical, Contex, Jiangsu Green Stone Optical (SETO), Conant

What are the Application segmentation covered in the Myopia and Presbyopia Treatment - Market report?

Ans: The Applications covered in the Myopia and Presbyopia Treatment - Market report are Myopia, Presbyopia

What are the Type segmentation covered in the Myopia and Presbyopia Treatment - Market report?

Ans: The Types covered in the Myopia and Presbyopia Treatment - Market report are Eyeglasses, Contact Lenses, Intra Ocular Lenses, Other

Recommended Reports

Ophthalmic Devices

Vision Correction

Eye Disease Treatment

1 Market Overview
1.1 Myopia and Presbyopia Treatment Product Introduction
1.2 Global Myopia and Presbyopia Treatment Market Size Forecast
1.3 Myopia and Presbyopia Treatment Market Trends & Drivers
1.3.1 Myopia and Presbyopia Treatment Industry Trends
1.3.2 Myopia and Presbyopia Treatment Market Drivers & Opportunity
1.3.3 Myopia and Presbyopia Treatment Market Challenges
1.3.4 Myopia and Presbyopia Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Myopia and Presbyopia Treatment Players Revenue Ranking (2023)
2.2 Global Myopia and Presbyopia Treatment Revenue by Company (2019-2024)
2.3 Key Companies Myopia and Presbyopia Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Myopia and Presbyopia Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Myopia and Presbyopia Treatment
2.6 Myopia and Presbyopia Treatment Market Competitive Analysis
2.6.1 Myopia and Presbyopia Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Myopia and Presbyopia Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myopia and Presbyopia Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Eyeglasses
3.1.2 Contact Lenses
3.1.3 Intra Ocular Lenses
3.1.4 Other
3.2 Global Myopia and Presbyopia Treatment Sales Value by Type
3.2.1 Global Myopia and Presbyopia Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Myopia and Presbyopia Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Myopia and Presbyopia Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Myopia
4.1.2 Presbyopia
4.2 Global Myopia and Presbyopia Treatment Sales Value by Application
4.2.1 Global Myopia and Presbyopia Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Myopia and Presbyopia Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Myopia and Presbyopia Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Myopia and Presbyopia Treatment Sales Value by Region
5.1.1 Global Myopia and Presbyopia Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Myopia and Presbyopia Treatment Sales Value by Region (2019-2024)
5.1.3 Global Myopia and Presbyopia Treatment Sales Value by Region (2025-2030)
5.1.4 Global Myopia and Presbyopia Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Myopia and Presbyopia Treatment Sales Value, 2019-2030
5.2.2 North America Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Myopia and Presbyopia Treatment Sales Value, 2019-2030
5.3.2 Europe Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Myopia and Presbyopia Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Myopia and Presbyopia Treatment Sales Value, 2019-2030
5.5.2 South America Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Myopia and Presbyopia Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Myopia and Presbyopia Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Myopia and Presbyopia Treatment Sales Value
6.3 United States
6.3.1 United States Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.3.2 United States Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.4.2 Europe Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.5.2 China Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.6.2 Japan Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.7.2 South Korea Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Myopia and Presbyopia Treatment Sales Value, 2019-2030
6.9.2 India Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Myopia and Presbyopia Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Profile
7.1.2 Novartis AG Main Business
7.1.3 Novartis AG Myopia and Presbyopia Treatment Products, Services and Solutions
7.1.4 Novartis AG Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Novartis AG Recent Developments
7.2 Bausch & Lomb
7.2.1 Bausch & Lomb Profile
7.2.2 Bausch & Lomb Main Business
7.2.3 Bausch & Lomb Myopia and Presbyopia Treatment Products, Services and Solutions
7.2.4 Bausch & Lomb Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bausch & Lomb Recent Developments
7.3 Nidek Co., Ltd
7.3.1 Nidek Co., Ltd Profile
7.3.2 Nidek Co., Ltd Main Business
7.3.3 Nidek Co., Ltd Myopia and Presbyopia Treatment Products, Services and Solutions
7.3.4 Nidek Co., Ltd Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Vision Recent Developments
7.4 Johnson & Johnson Vision
7.4.1 Johnson & Johnson Vision Profile
7.4.2 Johnson & Johnson Vision Main Business
7.4.3 Johnson & Johnson Vision Myopia and Presbyopia Treatment Products, Services and Solutions
7.4.4 Johnson & Johnson Vision Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Vision Recent Developments
7.5 Biotech Healthcare
7.5.1 Biotech Healthcare Profile
7.5.2 Biotech Healthcare Main Business
7.5.3 Biotech Healthcare Myopia and Presbyopia Treatment Products, Services and Solutions
7.5.4 Biotech Healthcare Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Biotech Healthcare Recent Developments
7.6 HumanOptics
7.6.1 HumanOptics Profile
7.6.2 HumanOptics Main Business
7.6.3 HumanOptics Myopia and Presbyopia Treatment Products, Services and Solutions
7.6.4 HumanOptics Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 HumanOptics Recent Developments
7.7 Wuxi Vision Pro Ltd
7.7.1 Wuxi Vision Pro Ltd Profile
7.7.2 Wuxi Vision Pro Ltd Main Business
7.7.3 Wuxi Vision Pro Ltd Myopia and Presbyopia Treatment Products, Services and Solutions
7.7.4 Wuxi Vision Pro Ltd Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Wuxi Vision Pro Ltd Recent Developments
7.8 HOYA Corporation
7.8.1 HOYA Corporation Profile
7.8.2 HOYA Corporation Main Business
7.8.3 HOYA Corporation Myopia and Presbyopia Treatment Products, Services and Solutions
7.8.4 HOYA Corporation Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 HOYA Corporation Recent Developments
7.9 ZEISS
7.9.1 ZEISS Profile
7.9.2 ZEISS Main Business
7.9.3 ZEISS Myopia and Presbyopia Treatment Products, Services and Solutions
7.9.4 ZEISS Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 ZEISS Recent Developments
7.10 EssilorLuxottica
7.10.1 EssilorLuxottica Profile
7.10.2 EssilorLuxottica Main Business
7.10.3 EssilorLuxottica Myopia and Presbyopia Treatment Products, Services and Solutions
7.10.4 EssilorLuxottica Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 EssilorLuxottica Recent Developments
7.11 CooperVision
7.11.1 CooperVision Profile
7.11.2 CooperVision Main Business
7.11.3 CooperVision Myopia and Presbyopia Treatment Products, Services and Solutions
7.11.4 CooperVision Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 CooperVision Recent Developments
7.12 Ovctek
7.12.1 Ovctek Profile
7.12.2 Ovctek Main Business
7.12.3 Ovctek Myopia and Presbyopia Treatment Products, Services and Solutions
7.12.4 Ovctek Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Ovctek Recent Developments
7.13 Alpha Corporation
7.13.1 Alpha Corporation Profile
7.13.2 Alpha Corporation Main Business
7.13.3 Alpha Corporation Myopia and Presbyopia Treatment Products, Services and Solutions
7.13.4 Alpha Corporation Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Alpha Corporation Recent Developments
7.14 EUCLID
7.14.1 EUCLID Profile
7.14.2 EUCLID Main Business
7.14.3 EUCLID Myopia and Presbyopia Treatment Products, Services and Solutions
7.14.4 EUCLID Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 EUCLID Recent Developments
7.15 Brighten Optix
7.15.1 Brighten Optix Profile
7.15.2 Brighten Optix Main Business
7.15.3 Brighten Optix Myopia and Presbyopia Treatment Products, Services and Solutions
7.15.4 Brighten Optix Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Brighten Optix Recent Developments
7.16 Lucid Korea
7.16.1 Lucid Korea Profile
7.16.2 Lucid Korea Main Business
7.16.3 Lucid Korea Myopia and Presbyopia Treatment Products, Services and Solutions
7.16.4 Lucid Korea Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Lucid Korea Recent Developments
7.17 WeiXing Optical
7.17.1 WeiXing Optical Profile
7.17.2 WeiXing Optical Main Business
7.17.3 WeiXing Optical Myopia and Presbyopia Treatment Products, Services and Solutions
7.17.4 WeiXing Optical Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 WeiXing Optical Recent Developments
7.18 Contex
7.18.1 Contex Profile
7.18.2 Contex Main Business
7.18.3 Contex Myopia and Presbyopia Treatment Products, Services and Solutions
7.18.4 Contex Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.18.5 Contex Recent Developments
7.19 Jiangsu Green Stone Optical (SETO)
7.19.1 Jiangsu Green Stone Optical (SETO) Profile
7.19.2 Jiangsu Green Stone Optical (SETO) Main Business
7.19.3 Jiangsu Green Stone Optical (SETO) Myopia and Presbyopia Treatment Products, Services and Solutions
7.19.4 Jiangsu Green Stone Optical (SETO) Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.19.5 Jiangsu Green Stone Optical (SETO) Recent Developments
7.20 Conant
7.20.1 Conant Profile
7.20.2 Conant Main Business
7.20.3 Conant Myopia and Presbyopia Treatment Products, Services and Solutions
7.20.4 Conant Myopia and Presbyopia Treatment Revenue (US$ Million) & (2019-2024)
7.20.5 Conant Recent Developments
8 Industry Chain Analysis
8.1 Myopia and Presbyopia Treatment Industrial Chain
8.2 Myopia and Presbyopia Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Myopia and Presbyopia Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Myopia and Presbyopia Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Myopia and Presbyopia Treatment Market Trends
    Table 2. Myopia and Presbyopia Treatment Market Drivers & Opportunity
    Table 3. Myopia and Presbyopia Treatment Market Challenges
    Table 4. Myopia and Presbyopia Treatment Market Restraints
    Table 5. Global Myopia and Presbyopia Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Myopia and Presbyopia Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Myopia and Presbyopia Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Myopia and Presbyopia Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Myopia and Presbyopia Treatment
    Table 10. Global Myopia and Presbyopia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myopia and Presbyopia Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Myopia and Presbyopia Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Myopia and Presbyopia Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Myopia and Presbyopia Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Myopia and Presbyopia Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Myopia and Presbyopia Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Myopia and Presbyopia Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Myopia and Presbyopia Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Myopia and Presbyopia Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Myopia and Presbyopia Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Myopia and Presbyopia Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Myopia and Presbyopia Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Myopia and Presbyopia Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Myopia and Presbyopia Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Myopia and Presbyopia Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Myopia and Presbyopia Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Myopia and Presbyopia Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Myopia and Presbyopia Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Myopia and Presbyopia Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novartis AG Basic Information List
    Table 32. Novartis AG Description and Business Overview
    Table 33. Novartis AG Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Novartis AG (2019-2024)
    Table 35. Novartis AG Recent Developments
    Table 36. Bausch & Lomb Basic Information List
    Table 37. Bausch & Lomb Description and Business Overview
    Table 38. Bausch & Lomb Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Bausch & Lomb (2019-2024)
    Table 40. Bausch & Lomb Recent Developments
    Table 41. Nidek Co., Ltd Basic Information List
    Table 42. Nidek Co., Ltd Description and Business Overview
    Table 43. Nidek Co., Ltd Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Nidek Co., Ltd (2019-2024)
    Table 45. Nidek Co., Ltd Recent Developments
    Table 46. Johnson & Johnson Vision Basic Information List
    Table 47. Johnson & Johnson Vision Description and Business Overview
    Table 48. Johnson & Johnson Vision Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Johnson & Johnson Vision (2019-2024)
    Table 50. Johnson & Johnson Vision Recent Developments
    Table 51. Biotech Healthcare Basic Information List
    Table 52. Biotech Healthcare Description and Business Overview
    Table 53. Biotech Healthcare Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Biotech Healthcare (2019-2024)
    Table 55. Biotech Healthcare Recent Developments
    Table 56. HumanOptics Basic Information List
    Table 57. HumanOptics Description and Business Overview
    Table 58. HumanOptics Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of HumanOptics (2019-2024)
    Table 60. HumanOptics Recent Developments
    Table 61. Wuxi Vision Pro Ltd Basic Information List
    Table 62. Wuxi Vision Pro Ltd Description and Business Overview
    Table 63. Wuxi Vision Pro Ltd Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Wuxi Vision Pro Ltd (2019-2024)
    Table 65. Wuxi Vision Pro Ltd Recent Developments
    Table 66. HOYA Corporation Basic Information List
    Table 67. HOYA Corporation Description and Business Overview
    Table 68. HOYA Corporation Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of HOYA Corporation (2019-2024)
    Table 70. HOYA Corporation Recent Developments
    Table 71. ZEISS Basic Information List
    Table 72. ZEISS Description and Business Overview
    Table 73. ZEISS Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of ZEISS (2019-2024)
    Table 75. ZEISS Recent Developments
    Table 76. EssilorLuxottica Basic Information List
    Table 77. EssilorLuxottica Description and Business Overview
    Table 78. EssilorLuxottica Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of EssilorLuxottica (2019-2024)
    Table 80. EssilorLuxottica Recent Developments
    Table 81. CooperVision Basic Information List
    Table 82. CooperVision Description and Business Overview
    Table 83. CooperVision Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of CooperVision (2019-2024)
    Table 85. CooperVision Recent Developments
    Table 86. Ovctek Basic Information List
    Table 87. Ovctek Description and Business Overview
    Table 88. Ovctek Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Ovctek (2019-2024)
    Table 90. Ovctek Recent Developments
    Table 91. Alpha Corporation Basic Information List
    Table 92. Alpha Corporation Description and Business Overview
    Table 93. Alpha Corporation Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Alpha Corporation (2019-2024)
    Table 95. Alpha Corporation Recent Developments
    Table 96. EUCLID Basic Information List
    Table 97. EUCLID Description and Business Overview
    Table 98. EUCLID Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of EUCLID (2019-2024)
    Table 100. EUCLID Recent Developments
    Table 101. Brighten Optix Basic Information List
    Table 102. Brighten Optix Description and Business Overview
    Table 103. Brighten Optix Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Brighten Optix (2019-2024)
    Table 105. Brighten Optix Recent Developments
    Table 106. Lucid Korea Basic Information List
    Table 107. Lucid Korea Description and Business Overview
    Table 108. Lucid Korea Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Lucid Korea (2019-2024)
    Table 110. Lucid Korea Recent Developments
    Table 111. WeiXing Optical Basic Information List
    Table 112. WeiXing Optical Description and Business Overview
    Table 113. WeiXing Optical Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of WeiXing Optical (2019-2024)
    Table 115. WeiXing Optical Recent Developments
    Table 116. Contex Basic Information List
    Table 117. Contex Description and Business Overview
    Table 118. Contex Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Contex (2019-2024)
    Table 120. Contex Recent Developments
    Table 121. Jiangsu Green Stone Optical (SETO) Basic Information List
    Table 122. Jiangsu Green Stone Optical (SETO) Description and Business Overview
    Table 123. Jiangsu Green Stone Optical (SETO) Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Jiangsu Green Stone Optical (SETO) (2019-2024)
    Table 125. Jiangsu Green Stone Optical (SETO) Recent Developments
    Table 126. Conant Basic Information List
    Table 127. Conant Description and Business Overview
    Table 128. Conant Myopia and Presbyopia Treatment Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Myopia and Presbyopia Treatment Business of Conant (2019-2024)
    Table 130. Conant Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Myopia and Presbyopia Treatment Downstream Customers
    Table 134. Myopia and Presbyopia Treatment Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Myopia and Presbyopia Treatment Product Picture
    Figure 2. Global Myopia and Presbyopia Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Myopia and Presbyopia Treatment Report Years Considered
    Figure 5. Global Myopia and Presbyopia Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Myopia and Presbyopia Treatment Revenue in 2023
    Figure 7. Myopia and Presbyopia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Eyeglasses Picture
    Figure 9. Contact Lenses Picture
    Figure 10. Intra Ocular Lenses Picture
    Figure 11. Other Picture
    Figure 12. Global Myopia and Presbyopia Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Myopia and Presbyopia Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Myopia
    Figure 15. Product Picture of Presbyopia
    Figure 16. Global Myopia and Presbyopia Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Myopia and Presbyopia Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Myopia and Presbyopia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Myopia and Presbyopia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Myopia and Presbyopia Treatment Sales Value (%), (2019-2030)
    Figure 29. United States Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Myopia and Presbyopia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Myopia and Presbyopia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Myopia and Presbyopia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. Myopia and Presbyopia Treatment Industrial Chain
    Figure 51. Myopia and Presbyopia Treatment Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart